Clinical Trials
6
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors
Withdrawn
- Conditions
- Cancer
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- EBG MedAustron GmbH
- Target Recruit Count
- 20
- Registration Number
- NCT06390657
- Locations
- 🇦🇹
EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria
Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)
Not Applicable
Recruiting
- Conditions
- Pancreas Cancer
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- EBG MedAustron GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT05191940
- Locations
- 🇦🇹
EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria
Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer
Not Applicable
Recruiting
- Conditions
- Pancreatic CancerProton Therapy
- Interventions
- Radiation: Proton IonsProcedure: Surgical resection of the pancreas (when feasible)
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- EBG MedAustron GmbH
- Target Recruit Count
- 10
- Registration Number
- NCT04894643
- Locations
- 🇦🇹
EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria
🇦🇹Department of Surgery, LK Wiener Neustadt, Wiener Neustadt, Austria
Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors
Not Applicable
Terminated
- Conditions
- Cancer
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- EBG MedAustron GmbH
- Target Recruit Count
- 13
- Registration Number
- NCT04875871
- Locations
- 🇦🇹
EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria
Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer
Not Applicable
Terminated
- Conditions
- Intermediate Risk Prostate CancerLow Risk Prostate Cancer
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- EBG MedAustron GmbH
- Target Recruit Count
- 5
- Registration Number
- NCT03740191
- Locations
- 🇦🇹
EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria
- Prev
- 1
- 2
- Next
News
No news found